Dermata Therapeutics Inc. (DRMAW)

AI Score

Unlock

0.02

-0.00 (-14.53%)

At close: Apr 17, 2025, 3:54 PM

0.02

0.00%

After-hours: Apr 17, 2025, 04:00 PM EDT

Dermata Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-12.51M	-11.53M	-10.12M	-8.97M	-8.04M	-7.53M	-8.17M	-9.17M	-9.67M	-10.52M	-9.78M	-8.38M	-7.86M	-5.8M	-4.62M	-4.09M	-3.17M	-2.68M	-2.14M	-1.35M
Interest Income	225.78K	262.29K	302.56K	278.97K	247.22K	203.44K	132.16K	101.11K	63.57K	21.49K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-12.29M	-11.27M	-9.82M	-8.69M	-7.79M	-7.33M	-8.04M	-9.06M	-9.61M	-10.49M	-9.78M	-8.38M	-7.9M	-5.75M	-4.63M	-4.12M	-3.24M	-2.84M	-2.24M	-1.42M
Net Income	-12.29M	-11.27M	-9.82M	-8.69M	-7.79M	-7.25M	-7.91M	-8.94M	-9.48M	-10.45M	-9.78M	-8.38M	-7.9M	-5.75M	-4.63M	-4.12M	-3.24M	-2.84M	-2.24M	-1.42M
Selling & General & Admin	4.31M	4.39M	4.47M	4.49M	3.97M	3.71M	3.69M	3.92M	4.02M	4.64M	4.66M	4.01M	4.4M	3.33M	2.84M	2.76M	1.57M	1.19M	768.31K	387.47K
Research & Development	8.2M	7.15M	5.65M	4.48M	4.07M	3.82M	4.47M	5.25M	5.65M	5.87M	5.12M	4.37M	3.46M	2.46M	1.78M	1.33M	1.61M	1.49M	1.37M	961.1K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	12.51M	11.53M	10.12M	8.97M	8.04M	7.53M	8.17M	9.17M	9.67M	10.52M	9.78M	8.38M	7.86M	5.8M	4.62M	4.09M	3.17M	2.68M	2.14M	1.35M
Interest Expense	n/a	37.54K	37.54K	37.54K	37.54K	42.09K	63.57K	63.57K	63.57K	45.59M	45.57M	45.57M	45.61M	84.09K	140.77K	167.81K	197.27K	158.79K	101.46K	72.6K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	12.51M	11.53M	10.12M	8.97M	8.04M	7.53M	8.17M	9.17M	9.67M	10.52M	9.78M	8.38M	7.86M	5.8M	4.62M	4.09M	3.17M	2.68M	2.14M	1.35M
Income Tax Expense	-3.2M	-3.21M	-3.21M	-3.21M	-5.76K	-87.72K	-128.88K	-2.86M	-5.64M	-51.13M	-51.08M	-48.35M	-45.57M	78.22K	25.55K	-25.49K	-25.41K	-103.87K	-51.12K	n/a
Shares Outstanding (Basic)	1.55M	1.55M	676.57K	444.06K	3.93M	3.19M	2.7M	65.72K	770.12K	767.27K	699.68K	520.54K	8.35M	311.27K	469.74K	520.54K	8.33M	520.54K	520.54K	520.54K
Shares Outstanding (Diluted)	1.55M	1.55M	676.57K	444.06K	3.93M	3.19M	2.7M	65.72K	770.12K	767.27K	699.68K	522.03K	8.35M	311.27K	469.74K	520.54K	8.33M	520.54K	520.54K	520.54K
EPS (Basic)	-15.32	-13.82	-12.32	-8.77	-35.79	-37.31	-39.87	-43.14	-14.41	-12.66	-15.06	-14	-13.08	-12.82	-8.47	-7.21	-5.51	-5.46	-4.31	-2.73
EPS (Diluted)	-15.32	-13.82	-12.32	-8.77	-35.79	-37.31	-39.87	-43.14	-14.4	-12.65	-15.05	-13.99	-13.08	-12.82	-8.47	-7.21	-5.51	-5.46	-4.31	-2.73
EBITDA	-9.31M	-8.24M	-6.83M	-5.68M	-7.96M	-5.82M	-6.46M	-7.45M	-7.96M	-10.52M	-9.78M	-8.38M	-7.86M	-5.66M	-4.49M	-3.95M	-3.04M	-2.68M	-2.14M	-1.35M
EBIT	-12.51M	-11.53M	-10.12M	-8.97M	-8.04M	-7.53M	-8.17M	-9.17M	-9.67M	-10.52M	-9.78M	-8.38M	-7.86M	-5.66M	-4.49M	-3.95M	-3.04M	-2.68M	-2.14M	-1.35M
Depreciation & Amortization	3.2M	5.42M	7.24M	8.97M	5.76M	5.26M	5.89M	6.89M	9.67M	7.96M	5.52M	2.79M	324.00	133.84K	186.5K	237.54K	237.78K	104.19K	51.44K	322.00